Eli Lilly and Company (LLY) closed Thursday, November 7, 2026, at $1,354, a decline of 1.00% over the prior 24 hours. The pullback extended a modest losing streak, with the stock also down 4.41% over the past seven days.
Despite the recent softness, Eli Lilly shares have posted a gain of 13.95% over the trailing 30-day period, suggesting the broader monthly trend remains strongly positive even as near-term momentum has faded.
The pharmaceutical giant's market capitalization stood at $1,215.63 billion as of the close, keeping it among the most valuable companies in the sector. The gap between the weekly loss and the monthly gain points to a period of consolidation following a sharp run-up in the stock's price.
Trading in LLY on Thursday reflected broader caution rather than any fundamental shift in the company's standing, based on the available price data. The stock's current level of $1,354 leaves it well above where it traded 30 days prior.
